ONTARIO, Calif., July 26, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today announced the pricing of a public offering of 5,000,000 units (the "Units") consisting of (i) one share of common stock, par value $ 0.0001 per share ("Common Stock") and (ii) one Series A Warrant to purchase one share of Common Stock ("Warrant") at a public offering price of $0.24 per Unit, for aggregate gross proceeds of $1.2 million, prior to deducting underwriting discounts and other offering expenses. The closing of the offering is expected ...

Sharpie Bus continues its "The World Is Your Canvas" tour to celebrate 60 years of innovation and new Sharpie Creative Markers ATLANTA, July 24, 2024 /PRNewswire/ -- Earlier this year, Sharpie®, part of Newell Brands' global portfolio, embarked on a cross-country journey with the brand-new Sharpie Bus as part of the brand's "The World Is Your Canvas" tour, which aims to ignite creativity in celebration of the brand's 60-year history. The tour takes place through the end of the year, visiting events and festivals across the U.S. With four stops in the books so far, the Sharpie Bus is headed to Comic-Con ...

Thirty-Fourth Consecutive Period of Record Revenue TUCSON, Ariz., July 25, 2024 /PRNewswire/ -- AudioEye, Inc. (Nasdaq: AEYE) ("AudioEye" or the "Company"), the industry-leading digital accessibility company, reported financial results for the second quarter ended June 30, 2024.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported on Pfizer Inc.’s announcement of positive topline results from the Phase 3 AFFINE trial (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gene therapy that Sangamo is co-developing with and licensing to Pfizer for the treatment of adults with moderately severe to severe hemophilia A.